Who
Paul Josephs
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Lifecore Biomedical.
In numbers
- Trades disclosed
- 12
- Buys
- 1
- Sells
- 0
- Bought
- $98K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 May 2024
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $185K40,413 at $4.57 | filing |
| 20 May 2026filed 21 May 2026 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $185K40,413 at $4.57 | filing |
| 8 Jul 2025filed 10 Jul 2025 | LFCR Lifecore Biomedicaloption or derivative · Biotechnology | SEC FORM 4 Code M | —150,000 | filing |
| 8 Jul 2025filed 10 Jul 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code M | —150,000 | filing |
| 8 Jul 2025filed 10 Jul 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $449K54,857 at $8.19 | filing |
| 20 May 2025filed 22 May 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $143K21,532 at $6.63 | filing |
| 8 Jan 2025filed 8 Jan 2025 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Bought | $98K17,000 at $5.74 | filing |
| 6 Dec 2024filed 10 Dec 2024 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —38,461 at $0.00 | filing |
| 6 Dec 2024filed 10 Dec 2024 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | $84K11,769 at $7.15 | filing |
| 20 May 2024filed 22 May 2024 | LFCR Lifecore Biomedicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500,000 at $0.00 | filing |
| 20 May 2024filed 22 May 2024 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —525,000 | filing |
| 20 May 2024filed 22 May 2024 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code F | —8,975 | filing |
News
Lifecore Biomedical (NASDAQ:LFCR) vs. Evolus (NASDAQ:EOLS) Head to Head ComparisonLFCR · themarketsdaily.com · 14 Oct 2026Contrasting Lifecore Biomedical (NASDAQ:LFCR) & Cumberland Pharmaceuticals (NASDAQ:CPIX)LFCR · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Paul Josephs; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.